Autopsy report · NCT03638011
A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine
Cause of deathStaffing, sites or logistics
“Standard of Care changed due to COVID-19 and thus had to stop the study.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year 9 months before it stopped.
- 71 participants enrolled.
- Results were posted on the registry 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Maimonides Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Caesarean Section
- Interventions
- Exparel
- Participants
- 71
- Sites
- 2
- Countries
- United States
Trials that died the same way
- The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
“Study ended early due to COVID-19” - Effects of Community-center Based Dietary Intervention on Frailty Prevention and Regression in the Elderly.
“Due to the impacts of COVID-19, the study had to terminate.” - Better Together: Reablement and Caregivers
“Due to COVID-related issues had to change study design.” - Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients
“COVID patients admitted to the hospital during the study dates did NOT have the criteria to enter the study(i.e they were too medically unstable) or their hospital stay was too short to conduct a before and after assessment” - New Formulations of Propafenone to Treat Atrial Fibrillation
“Study halted/terminated prematurely due to COVID.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.